Restoring balance to B cells in ADA deficiency

Journal of Clinical Investigation

Volumn 122, Issue 6, 2012, Pages 1960-1962

  Luning Prak, Eline T ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; ENZYME INHIBITOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ADENOSINE DEAMINASE DEFICIENCY; APOPTOSIS; AUTOIMMUNE THROMBOCYTOPENIA; AUTOIMMUNITY; B LYMPHOCYTE; CELL CYCLE CHECKPOINT; ENZYME REPLACEMENT; GENE THERAPY; HEMOLYTIC ANEMIA; HOMEOSTASIS; HUMAN; HYPERSENSITIVITY; HYPOPLASIA; HYPOTHYROIDISM; IMMUNOLOGICAL TOLERANCE; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIGHT CHAIN; LYMPHOCYTOPENIA; NATURAL KILLER CELL; NONHUMAN; NOTE; NUCLEIC ACID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RETROVIRUS; T LYMPHOCYTE; VACCINATION;

ADENOSINE DEAMINASE; B-LYMPHOCYTES; FEMALE; GENE THERAPY; HUMANS; IMMUNE TOLERANCE; MALE; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, ANTIGEN, T-CELL; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84861813348     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI63782     Document Type: Note

References (16)

1. Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972;2(7786):1067-1069.
2. Blackburn MR, Kellems RE. Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol. 2005;86:1-41. (Pubitemid 40215689)
3. Carson DA, Kaye J, Seegmiller JE. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s). Proc Natl Acad Sci U S A. 1977;74(12):5677-5681.
4. Thompson LF, et al. Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures. J Clin Invest. 2000;106(9):1149-1157.
5. Apasov SG, Blackburn MR, Kellems RE, Smith PT, Sitkovsky MV. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling. J Clin Invest. 2001;108(1):131-141. (Pubitemid 32634930)
6. Blackburn MR, Datta SK, Kellems RE. Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency. J Biol Chem. 1998;273(9):5093-5100. (Pubitemid 28108669)
7. Aldrich MB, Chen W, Blackburn MR, Martinez-Valdez H, Datta SK, Kellems RE. Impaired germinal center maturation in adenosine deaminase deficiency. J Immunol. 2003;171(10):5562-5570. (Pubitemid 37432847)
8. Junger WG. Immune cell regulation by autocrine purinergic signalling. Nat Rev Immunol. 2011;11(3):201-212.
9. Sauer AV, Aiuti A. New insights into the pathogenesis of adenosine deaminase-severe combined immunodeficiency and progress in gene therapy. Curr Opin Allergy Clin Immunol. 2009;9(6):496-502.
10. Sauer AV, et al. Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID. Blood. 2012;119(6):1428-1439.
11. Cancro MP, D'Cruz DP, Khamashta MA. The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus. J Clin Invest. 2009;119(5):1066-1073.
12. Sauer AV, Morbach H, Brigida I, Ng Y-S, Aiuti A, Meffre E. Defective B cell tolerance in adenosine deaminase deficiency is corrected by gene therapy. J Clin Invest. 2012;122(6):2141-2152.
13. Minguet S, Huber M, Rosenkranz L, Schamel WW, Reth M, Brummer T. Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol. 2005;35(1):31-41. (Pubitemid 40123849)
14. Meffre E. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann N Y Acad Sci. 2011;1246:1-10.
15. Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6(10):728-740. (Pubitemid 44453459)
16. Morris SC, Cheek RL, Cohen PL, Eisenberg RA. Autoantibodies in chronic graft versus host result from cognate T-B interactions. J Exp Med. 1990;171(2):503-517. (Pubitemid 20059044)